Clinical trial
Treatment of Uterine Fibroids With Asoprisnil(J867)
NCT00152269 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00152269 |
|---|---|
| Title | Treatment of Uterine Fibroids With Asoprisnil(J867) |
| Official title | A Phase III, 12-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety (Including Bone Density Assessment) of Two Doses of J867 Versus Placebo in Subjects With Uterine Leiomyomata |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leiomyoma, Menorrhagia, Metrorrhagia |
| Intervention type | Drug |
| Interventions | Asoprisnil, Placebo |
| Enrollment | 475 |
| Start date | Jul 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: